Fesarius Therapeutics is to develop engineered skin replacement products.
Fesarius Therapeutics has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in June 2026.
Fesarius Therapeutics's investors include Johnson & Johnson Innovation, National Institutes of Health, New York Ventures, NIAMS, American Society of Plastic Surgeons.
Fesarius Therapeutics is headquartered in Brooklyn, United States.
Fesarius Therapeutics is to develop engineered skin replacement products.
Fesarius Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fesarius Therapeutics — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/fesarius-therapeutics. Accessed July 19, 2026.
VCBacked. (2026). Fesarius Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/fesarius-therapeutics
{{cite web |title=Fesarius Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/fesarius-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated